Company intelligence / Profile preview

Orsini

Elk Grove Village, Illinois, United States

Ownership: Private
Employees: ~201
Development stage: Other

Overview

Orsini operates as a specialty pharmacy leader in rare diseases and gene therapies, offering pharmacy distribution, patient services, home infusion, and manufacturer/commercialization programs. They are exclusive pharmacy partner for products such as Ionis’ DAWNZERA (donidalorsen) for hereditary angioedema and play a major role in launching specialty and orphan drugs for multiple manufacturers. Orsini is fully accredited and holds distinctions for rare disease and orphan drug care.

Therapeutic areas: ImmunologyEndocrinologyMetabolic DisordersOphthalmologyRare DiseasesHematologyPulmonologyNeurology
Modalities: Small moleculeBiologicGene therapyAntibodyEnzyme replacement therapy
Industry: Non-Academic Healthcare

Partnerships

Ionis PharmaceuticalsPTC TherapeuticsKalVistaAscendis Pharma

Beyond the preview

Go deeper on Orsini.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orsini.

Explore the full profile